Medical Management of Ectopic Pregnancy: A Prospective Study in a Tertiary Care Hospital
DOI:
https://doi.org/10.21276/w1460m14Keywords:
Ectopic pregnancy, Methotrexate Conservative treatmentAbstract
Background: Ectopic pregnancy is a deadly condition associated with comparatively high maternal mortality and morbidity. Extrauterine pregnancy is a complication of the first trimester of pregnancy that carries major morbidity and mortality.
Methods: This study was conducted in the department of gynecology at Govt Medical College, Saharanpur for the duration of 2 years. Every patient was explained the treatment options available, and a consent was taken. For this study 44 successive ultrasound proven cases of unruptured ectopic pregnancy were commissioned. These must not have any of the exclusion criteria listed below
Results: The conservative treatment offered failed in three patients thus giving a success rate of 93.18%.
Conclusion: Medical treatment with Methotrexate in properly selected cases is the treatment of choice but the patients should be properly monitored after its administration.
Downloads
References
Kamwendo F, Forslin L, Bodin L, Danielsson D. Epidemiology of
ectopic pregnancy during a 28 year period and the role of pelvic
inflavmmatory disease. KSex Transm Infect. 2000 Feb;76(1):28-
[PubMed]
Ankum W, Mol BW, Van der Veen F, Bossuyt P. Risk factors for
ectopic pregnancy: a meta-analysis.Fertil Steril. 1996
Jun;65(6):1093-9.[PubMed]
Dubuisson JB, Aubriot FX, Mathieu L, Foulot H, Mandelbrot L, de
Joliere JB. Risk factors for ectopic pregnancy in 556 pregnancies
after in vitro fertilization: implications for preventive management.
Fertil Steril. 1991 Oct;56(4):686-90. [PubMed]
Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG, Ling FW.
Predictors of success of methotrexate treatment in women with tubal
ectopic pregnancies. N Engl J Med. 1999;341:1974–8. [PubMed]
T.Tanaka, H. Hayashi, T. Kutsuzawa, S. Fujimoto, and K. Ichinoe,
“Treatment of interstitial ectopic pregnancy with methotrexate: report
of a successful case,” Fertility jb and Sterility, vol. 37, no. 6, pp. 851–
, 1982.View at:
Khaled B Soliman, Maureen M. Sale, Alla A Omran. Safety and
Efficacy of Systemic Methotrexate in the treatment of Unruptured
Tubal Pregnancy. >Saudi Med J. 2006 Jul27(7):1005-10.
M. Skubisz, P. Dutton, W. C. Duncan, A. W. Horne, and S. Tong,
“Using a decline in serum hCG between days 0–4 to predict ectopic
pregnancy treatment success after single-dose methotrexate: a
retrospective cohort study,” BMC Pregnancy and Childbirth, vol. 13,
article 30, 2013.
A Tawfiq, A.F Agameya, P. Claman Predictors of treatment failure
for ectopic pregnancy treated with single-dose methotrexate. Fertil
Steril 2000. Nov;74(5):877-880 10.1016/S0015-0282(00)01547-8
[PubMed] [CrossRef] [Google Scholar]
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
